These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30119201)

  • 1. Synergistic antitumour effects of triptolide plus gemcitabine in bladder cancer.
    Yang Y; Zhang LJ; Bai XG; Xu HJ; Jin ZL; Ding M
    Biomed Pharmacother; 2018 Oct; 106():1307-1316. PubMed ID: 30119201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic antitumour effects of triptolide plus 10-hydroxycamptothecin onbladder cancer.
    Wang T; Ding Y; Yang Y; Wang Z; Gao W; Li D; Wei J; Sun Y
    Biomed Pharmacother; 2019 Jul; 115():108899. PubMed ID: 31063955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triptolide Induces Apoptosis and Synergizes with Cisplatin in Cisplatin-Resistant HNE1/DDP Nasopharyngeal Cancer Cells.
    Wang X; Zhang JJ; Sun YM; Zhang J; Wang LR; Li JC; Liu H
    Folia Biol (Praha); 2015; 61(5):195-202. PubMed ID: 26667576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3β pathway.
    Wang J; Zhang Y; Liu X; Wang J; Li B; Liu Y; Wang J
    Int J Mol Med; 2019 Sep; 44(3):1026-1038. PubMed ID: 31524219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway.
    Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M
    Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide induces S phase arrest via the inhibition of cyclin E and CDC25A and triggers apoptosis via caspase- and mitochondrial-dependent signaling pathways in A375.S2 human melanoma cells.
    Hung FM; Chen YL; Huang AC; Hsiao YP; Yang JS; Chung MT; Chueh FS; Lu HF; Chung JG
    Oncol Rep; 2013 Mar; 29(3):1053-60. PubMed ID: 23314229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.
    Lin Y; Peng N; Li J; Zhuang H; Hua ZC
    Mol Cancer; 2013 Jun; 12():54. PubMed ID: 23758884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo.
    Liu Y; Xiao E; Yuan L; Li G
    DNA Cell Biol; 2014 Jul; 33(7):418-25. PubMed ID: 24720675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine.
    Jiang QW; Cheng KJ; Mei XL; Qiu JG; Zhang WJ; Xue YQ; Qin WM; Yang Y; Zheng DW; Chen Y; Wei MN; Zhang X; Lv M; Chen MW; Wei X; Shi Z
    Oncotarget; 2015 Oct; 6(32):32790-804. PubMed ID: 26447544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138.
    Zhang H; Li H; Liu Z; Ge A; Guo E; Liu S; Chen Z
    J Cell Biochem; 2018 Dec; 119(12):9866-9877. PubMed ID: 30156009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21.
    Liu J; Shen M; Yue Z; Yang Z; Wang M; Li C; Xin C; Wang Y; Mei Q; Wang Z
    Phytomedicine; 2012 Jun; 19(8-9):756-62. PubMed ID: 22464014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triptolide enhances TRAIL sensitivity of pancreatic cancer cells by activating autophagy via downregulation of PUM1.
    Dai H; Jiang Y; Luo Y; Bie P; Chen Z
    Phytomedicine; 2019 Sep; 62():152953. PubMed ID: 31128486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells.
    Ho JN; Byun SS; Lee S; Oh JJ; Hong SK; Lee SE; Yeon JS
    J Urol; 2015 Mar; 193(3):1016-22. PubMed ID: 25229559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptolide triggers the apoptosis of pancreatic cancer cells via the downregulation of Decoy receptor 3 expression.
    Wang W; Li X; Sun W; Zhang L; Zhang M; Hong B; Lv G
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1597-605. PubMed ID: 22581262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide inhibits PDGF-induced proliferation of ASMCs through G0/G1 cell cycle arrest and suppression of the AKT/NF-κB/cyclinD1 signaling pathway.
    He S; Chen M; Lin X; Lv Z; Liang R; Huang L
    Eur J Pharmacol; 2020 Jan; 867():172811. PubMed ID: 31756335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of a combination of S-1 and gemcitabine on cell cycle regulation in pancreatic cancer cell lines.
    Morimoto Y; Takeuchi O; Takizawa A; Yoneyama H; Asanuma F; Suzuki Y; Atsuda K; Yamada Y
    Anticancer Drugs; 2012 Jun; 23(5):505-14. PubMed ID: 22334000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells.
    Takeuchi H; Mmeje CO; Jinesh GG; Taoka R; Kamat AM
    Oncol Rep; 2015 Nov; 34(5):2738-44. PubMed ID: 26323344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triptolide inhibits benign prostatic epithelium viability and migration and induces apoptosis via upregulation of microRNA-218.
    Yao C; Li H; Zhang W
    Int J Immunopathol Pharmacol; 2018; 32():2058738418812349. PubMed ID: 30453799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine enhances gemcitabine‑induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.
    Gao X; Liu J; Fan D; Li X; Fang Z; Yan K; Fan Y
    Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34935059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide cooperates with Cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer.
    Zhu W; Li J; Wu S; Li S; Le L; Su X; Qiu P; Hu H; Yan G
    Pancreas; 2012 Oct; 41(7):1029-38. PubMed ID: 22617708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.